In conjunction with the publication of the interim report for the first quarter of 2022, Isofol invites investors, analysts, and media to an audiocast on
Date and time
Webcast link
https://tv.streamfabriken.com/isofol-medical-q1-2022
Phone number
To participate via telephone, please dial one of the numbers below.
SE: +46 8 50 55 83 53
US: +1 631 913 1422 PIN: 80079640#
The presentation will also be available on Isofol's website after the broadcast:
https://isofolmedical.com/company-presentations/
For further information, please contact
Ulf Jungnelius, M.D., Chief Executive Officer
E-mail: jungnelius@isofolmedical.com
Phone: +46 (0) 709 16 89 55
Gustaf Albèrt, CFO
E-mail: gustaf.albert@isofolmedical.com
Phone: +46 (0)709 16 83 02
The information was submitted for publication, through the agency of the contact person set out above, at
About Isofol Medical AB (publ)
www.isofolmedical.com
https://news.cision.com/isofol-medical-ab--publ-/r/invitation-to-presentation-of-isofol-s-report-for-the-first-quarter-of-2022,c3558695
https://mb.cision.com/Main/15598/3558695/1573451.pdf
(c) 2022 Cision. All rights reserved., source